摘要
目的建立HPLC波长切换联合梯度洗脱法同时测定参苏宣肺丸中咖啡酸、迷迭香酸、3'-羟基葛根素、葛根素、3'-甲氧基葛根素、大豆苷的含量。方法采用ZOBAX SB-C18色谱柱(4.6 mm×250 mm,5μm);流动相A为甲醇-乙腈(1∶1),流动相B为0.1%冰醋酸溶液,进行梯度洗脱;流速为1.0 m L·min-1;咖啡酸和迷迭香酸的检测波长为320 nm,3'-羟基葛根素、葛根素、3'-甲氧基葛根素和大豆苷的检测波长为250 nm;进样量为20μL。结果咖啡酸、迷迭香酸、3'-羟基葛根素、葛根素、3'-甲氧基葛根素、大豆苷的浓度与峰面积分别在2.32-46.40μg·m L-1(r=0.999 8)、3.06-61.20μg·m L-1(r=0.999 5)、4.45-89.00μg·m L-1(r=0.999 9)、14.48-289.60μg·m L-1(r=0.999 9)、4.86-97.20μg·m L-1(r=0.999 7)、3.69-73.80μg·m L-1(r=0.999 6)内具有较好的线性关系,平均加样回收率和相应的RSD分别为99.0%(1.6%),97.5%(0.6%),99.3%(0.9%),98.6%(1.3%),97.6%(1.3%),97.0%(0.9%)。结论方法操作准确、简便,可用于参苏宣肺丸的质量控制。
OBJECTIVE To develop an HPLC with wavelength switching combined gradient elution method for simultaneous determination of caffeic acid, rosmarinic acid, 3'-hydroxy puerarin, puerarin, 3'-methoxypuerarin and daidzin in Shensu Xuanfei Wan. METHODS ZOBAX SB-C18 column(4.6 mm×250 mm,5 μm) was applied with methanol-acetonitrile(1∶1)(A) and 0.1% glacial acetic acid solution(B) as mobile phase in gradient mode. The flow rate was 1.0 m L·min-1. Caffeic acid and rosmarinic acid were detected at 320 nm, 3'-hydroxy puerarin, puerarin, 3'-methoxypuerarin and daidzin were detected at 250 nm. Injection volume was 20 μL. RESULTS The concentration and peak area of caffeic acid, rosmarinic acid, 3'-hydroxy puerarin, puerarin, 3'-methoxypuerarin and daidzin were at 2.32-46.40 μg·m L-1(r=0.999 8), 3.06-61.20 μg·m L-1(r=0.999 5), 4.45-89.00 μg·m L-1(r=0.999 9), 14.48-289.60 μg·m L-1(r=0.999 9), 4.86-97.20 μg·m L-1(r=0.999 7), 3.69-73.80 μg·m L-1(r=0.999 6), respectively, and showed a good linear relationship. The average recoveries and the corresponding RSD were 99.0%(1.6%), 97.5%(0.6%), 99.3%(0.9%), 98.6%(1.3%), 97.6%(1.3%), 97.0%(0.9%), respectively. CONCLUSION The method is accurate, quick, simple. It could be reliable for the quality control of Shensu Xuanfei Wan.
作者
高森
白雪
文柳静
王鑫
李正翔
房志仲
GAO Sen BAI Xue WEN Liujing WANG Xin LI Zhengxiang FANG Zhazhong(Department of Pharmacy, General Hospital, Tianjin Medical University, Tianjin 300052, China Tasly Holding Group Academy of Traditional Chinese Medicine Development Center, State Key Laboratory of Chinese Medicine Key Technology Innovation, Tianjin 300402, China Department of Pharmacy, Tianjin Medical University Cancer Hospital, State Cancer Clinical Medical Research Center, Tianjin Key Lab of Cancer Prevention and Treatment, Tianjin 300060, China College of Pharmacy, Tianjin Medical University, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranosties), Tianjin 300070, China)
出处
《中国现代应用药学》
CAS
CSCD
2016年第10期1300-1304,共5页
Chinese Journal of Modern Applied Pharmacy